Search results
Results from the WOW.Com Content Network
Cannabinoid receptor type 1 (CB 1) receptors are thought to be one of the most widely expressed G αi protein-coupled receptors in the brain. One mechanism through which they function is endocannabinoid-mediated depolarization-induced suppression of inhibition , a very common form of retrograde signaling , in which the depolarization of a ...
The plant-biosynthesized cannabinoid cannabidiol also shows "either direct or indirect activation" of TRPV1 receptors. [69] [42] TRPV1 colocalizes with CB1 receptors and CB2 receptors in sensory and brain neurons respectively, and other plant-cannabinoids like CBN, CBG, CBC, THCV, and CBDV are also agonists of this ion channel.
The use of the cannabinoid agonist, THC, in its many preparations to enhance appetite is a well known fact. This fact led to the logical extension that blocking of the cannabinoid receptors might be useful in decreasing appetite and food intake. [11] It was then discovered that the blockage of the CB 1 receptor represented a new pharmacological ...
MDA-19 (also known as BZO-HEXOXIZID) [2] [3] is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB 2, with reasonable selectivity over the psychoactive CB 1 receptor, though with some variation between species.
An analog of oleoylethanolamide, the endogenous agonist for proliferator-activated receptor α . It also acts as a weak cannabinoid agonist. AM-4030: 0.7: 8.6: CB 1 (12×) 6.17: A potent agonist at both CB 1 and CB 2, it is dodecally selective for CB 1. It is a derivative of HU-210 and represents a hybrid structure between the classical and ...
WIN 55,212-2 is a potent cannabinoid receptor agonist [6] that has been found to be a potent analgesic [7] in a rat model of neuropathic pain. [8] It activates p42 and p44 MAP kinase via receptor-mediated signaling. [9] At 5 μM WIN 55,212-2 inhibits ATP production in sperm in a CB 1 receptor-dependent fashion. [10]
Cannabinoid receptor 1 (CB1), is a G protein-coupled cannabinoid receptor that in humans is encoded by the CNR1 gene. [5] And discovered, by determination and characterization in 1988, [6] and cloned in 1990 for the first time.
Compared to THC, which is a partial agonist at CB 1 receptors, JWH-018, and many synthetic cannabinoids, are full agonists. JWH-018 may cause intense anxiety, agitation, and in rare cases, has been assumed to have been the cause of seizures and convulsions. JWH-018 and analogs of it may present serious dangers to the user when used to excess. [22]